These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15464164)

  • 1. Pathomechanisms and molecular basis of membranous glomerulopathy.
    Kerjaschki D
    Lancet; 2004 Oct 2-8; 364(9441):1194-6. PubMed ID: 15464164
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.
    Debiec H; Nauta J; Coulet F; van der Burg M; Guigonis V; Schurmans T; de Heer E; Soubrier F; Janssen F; Ronco P
    Lancet; 2004 Oct 2-8; 364(9441):1252-9. PubMed ID: 15464186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenic mechanism of membranous glomerulonephritis obtained from Heymann nephritis and human membranous glomerulonephritis].
    Kamata K
    Nihon Jinzo Gakkai Shi; 2011; 53(5):672-6. PubMed ID: 21842599
    [No Abstract]   [Full Text] [Related]  

  • 4. Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases.
    Debiec H; Guigonis V; Mougenot B; Haymann JP; Bensman A; Deschênes G; Ronco PM
    J Am Soc Nephrol; 2003 Jun; 14 Suppl 1():S27-32. PubMed ID: 12761235
    [No Abstract]   [Full Text] [Related]  

  • 5. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
    Ronco P; Debiec H
    Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic targets in membranous glomerulonephritis.
    Ronco P; Allegril ; Brianti E; Chatelet F; Van Leer EH; Veroust P; Richet G
    Pol Arch Med Wewn; 1988 Oct; 80(4):178-88. PubMed ID: 2978727
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous glomerulonephritis.
    Ulrich W
    Nephrol Dial Transplant; 1996 Oct; 11(10):2099-100. PubMed ID: 8918736
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2006 Jul; 17(7):1772-4. PubMed ID: 16775025
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy.
    Hu P; Xuan Q; Hu B; Lu L; Qin YH
    Mol Biol Rep; 2013 Apr; 40(4):2963-7. PubMed ID: 23271116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous glomerulonephritis (membranous nephropathy): Pathogenesis, pathophysiology, and therapy].
    Ohashi T; Uchida K; Yumura W
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():417-21. PubMed ID: 16523925
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extra-membranous glomerulonephritis: from the experimental model to the human pathology of new-born and adult].
    Ronco P
    Bull Mem Acad R Med Belg; 2008; 163(3-4):179-86; discussion 186-8. PubMed ID: 19025206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extra-membranous glomerulonephritis: report of a family and new physiopathological concepts].
    Debiec H; Guigonis V; Mougenot B; Haymann JP; Bensman A; Deschênes G; Ronco P
    Bull Acad Natl Med; 2003; 187(5):921-32; discussion 932-4. PubMed ID: 14979057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrillary glomerulonephritis].
    Varshavskiĭ VA; Golitsyna EP
    Arkh Patol; 2008; 70(5):31-4. PubMed ID: 19137781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heymann nephritis revisited--new insights into the pathogenesis of experimental membranous glomerulonephritis.
    De Heer E; Bruijn JA; Hoedemaeker PJ
    Clin Exp Immunol; 1993 Dec; 94(3):393-4. PubMed ID: 8252799
    [No Abstract]   [Full Text] [Related]  

  • 18. Membranous nephropathy: a long road but well traveled.
    Couser WG
    J Am Soc Nephrol; 2005 May; 16(5):1184-7. PubMed ID: 15800114
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
    Davenport A; Maciver AG; Hall CL; MacKenzie JC
    Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.